138 related articles for article (PubMed ID: 8958216)
1. Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources.
Chen L; Pulsipher M; Chen D; Sieff C; Elias A; Fine HA; Kufe DW
J Clin Invest; 1996 Dec; 98(11):2539-48. PubMed ID: 8958216
[TBL] [Abstract][Full Text] [Related]
2. Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation.
Marini FC; Snell V; Yu Q; Zhang X; Singletary SE; Champlin R; Andreeff M
Clin Cancer Res; 1999 Jun; 5(6):1557-68. PubMed ID: 10389945
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus vector-based purging of multiple myeloma cells.
Teoh G; Chen L; Urashima M; Tai YT; Celi LA; Chen D; Chauhan D; Ogata A; Finberg RW; Webb IJ; Kufe DW; Anderson KC
Blood; 1998 Dec; 92(12):4591-601. PubMed ID: 9845525
[TBL] [Abstract][Full Text] [Related]
4. Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support.
Papadopoulos KP; Ayello J; Tugulea S; Heitjan DF; Williams C; Reiss RF; Vahdat LT; Suciu-Foca N; Antman KH; Hesdorffer CS
J Hematother; 1997 Feb; 6(1):61-8. PubMed ID: 9112219
[TBL] [Abstract][Full Text] [Related]
5. Optimization of CD34+ cell selection using immunomagnetic beads: implications for use in cryopreserved peripheral blood stem cell collections.
Farley TJ; Ahmed T; Fitzgerald M; Preti RA
J Hematother; 1997 Feb; 6(1):53-60. PubMed ID: 9112218
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-mobilized peripheral blood CD34+Thy-1+Lin- human hematopoietic stem cells as target cells for transplantation-based gene therapy.
Chen BP; Fraser C; Reading C; Murray L; Uchida N; Galy A; Sasaki D; Tricot G; Jagannath S; Barlogie B
Leukemia; 1995 Oct; 9 Suppl 1():S17-25. PubMed ID: 7475307
[TBL] [Abstract][Full Text] [Related]
7. Biological characterization of CD34+ cells mobilized into peripheral blood.
Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
[TBL] [Abstract][Full Text] [Related]
8. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
9. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
[TBL] [Abstract][Full Text] [Related]
10. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients.
Lillo R; Ramírez M; Alvarez A; Santos S; García-Castro J; Fernández de Velasco J; Avilés MJ; Gómez-Pineda A; Díez JL; Balas A; Vicario JL; Bueren JA; García-Sánchez F
Cancer Res; 2002 Sep; 62(17):5013-8. PubMed ID: 12208755
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
12. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
13. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
[TBL] [Abstract][Full Text] [Related]
15. Efficient adenoviral vector transduction of human hematopoietic SCID-repopulating and long-term culture-initiating cells.
Fan X; Brun A; Segrén S; Jacobsen SE; Karlsson S
Hum Gene Ther; 2000 Jun; 11(9):1313-27. PubMed ID: 10890741
[TBL] [Abstract][Full Text] [Related]
16. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
Lemoli RM; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
Acta Haematol; 1996; 95(3-4):164-70. PubMed ID: 8677737
[TBL] [Abstract][Full Text] [Related]
17. Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation.
Schriber JR; Dejbakhsh-Jones S; Kusnierz-Glaz CR; Ginzton N; Still B; Negrin RS; Greenberg P; Strober S
Exp Hematol; 1995 Aug; 23(9):1024-9. PubMed ID: 7543414
[TBL] [Abstract][Full Text] [Related]
18. Primitive hematopoietic progenitor cells are present in peripheral blood autografts.
Tong J; Gianni AM; Siena S; Srour EF; Bregni M; Hoffman R
Blood Cells; 1994; 20(2-3):351-62; discussion 362-3. PubMed ID: 7538339
[TBL] [Abstract][Full Text] [Related]
19. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.
La Russa VF; Griffin JD; Kessler SW; Cutting MA; Knight RD; Blattler WA; Lambert JM; Wright DG
Exp Hematol; 1992 May; 20(4):442-8. PubMed ID: 1373688
[TBL] [Abstract][Full Text] [Related]
20. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]